Drug Profile
SM 8849
Alternative Names: SM-8849Latest Information Update: 30 Aug 2007
Price :
$50
*
At a glance
- Originator Sumitomo Pharmaceuticals
- Class Antirheumatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis